Frequency and severity of biochemical abnormalities with paritaprevir/ritonavir/ombitasvir /- ribavirin in a real-world cohort of HCV Genotype 1 patients - predictors and clinical significance

John Lubel, Joanne Mitchell, Stephen Pianko, Alex J Thompson, David M Iser, Alessia Gazzola, Sarah Chivers, Gauri Mishra, John Gough, Simone I Strasser, Gregory Dore, Katherine A Stuart, Jacob George, Edmund Tse, Amany Zekry, Miriam Levy, Gerry C MacQuillan, Vince Fragomeli, Paul Gow, Brenda Morales Show all